Evidence map›Paper›PMID 35008058›Full record

ArticleThe American journal of tropical medicine and hygiene2022

Epidemiological Characteristics and Risk Factors Related to Drug-resistant Tuberculosis in Luanda, Angola.

Cruz S Sebastião, João Samulengo, Euclides Sacomboio, Ngiambudulu M Francisco, Carlos Teixeira, Samuel António, Mizele Kinanga, Zoraima Neto, Joana Paixão, António Mateus and 3 more

Open access · greenAbstract read
In one paragraph

Article in The American journal of tropical medicine and hygiene, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.6field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Observational
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 2 countries.

Cruz S SebastiãoInstituto Nacional de Investigação em Saúde, Luanda, Angola.
João SamulengoInstituto Nacional de Investigação em Saúde, Luanda, Angola.
Euclides SacomboioInstituto Nacional de Investigação em Saúde, Luanda, Angola.
Ngiambudulu M FranciscoInstituto Nacional de Investigação em Saúde, Luanda, Angola.
Carlos TeixeiraInstituto Nacional de Investigação em Saúde, Luanda, Angola.
Samuel AntónioInstituto Nacional de Investigação em Saúde, Luanda, Angola.
Mizele KinangaInstituto Superior de Educação Física e Desporto, Luanda, Angola.
Zoraima NetoInstituto Nacional de Investigação em Saúde, Luanda, Angola.
Joana PaixãoInstituto Nacional de Investigação em Saúde, Luanda, Angola.
António MateusInstituto Nacional de Investigação em Saúde, Luanda, Angola.
Zinga DavidInstituto Nacional de Investigação em Saúde, Luanda, Angola.
Jocelyne Neto de VasconcelosInstituto Nacional de Investigação em Saúde, Luanda, Angola.
Joana MoraisInstituto Nacional de Investigação em Saúde, Luanda, Angola.
Agostinho Neto University · AOInstituto Nacional de Saúde · MZUniversidade Lusíada de Angola · AO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tuberculosis (TB) is a major cause of illness and public health concern, especially in resource-limited countries. This study analyzed the characteristics related to anti-TB drug resistance. Moreover, we examined the evidence-based indications for the treatment of active TB in Angola. This study evaluated the medical records of 176 patients screened for TB from January to September 2016 in Luanda, the capital city of Angola. Approximately 66.5% of the patients were newly diagnosed with active TB. The residence area showed a significant relationship with TB (P = 0.025), whereas age group (P = 0.272), gender (P = 0.853), and HIV status (P = 0.284) did not showed any relationship with TB. Overall, 72.4% of TB patients had resistance to at least one of the anti-TB drugs. The risk of anti-TB drug resistance was higher in males (odds ratio [OR]: 1.22; 95% confidence interval [CI]: 0.42-3.58, P = 0.685] and in TB-HIV coinfected patients [OR: 1.39; (95% CI: 0.26-7.28), P = 0.700], whereas it was lower in patients aged 30 years or older (OR: 0.56; 95% CI: 0.18-1.69) P = 0.303) and in patients living in urbanized areas (OR: 0.74; 95% CI: 0.17-3.25; P = 0.685). Our findings showed that drug-resistant TB is emerging in Angola. Further studies on factors related to anti-TB drug resistance are urgently needed to ascertain the magnitude of the problem and to proffer strategies toward TB control in Angola.

Indexed as

HIV InfectionsMycobacterium tuberculosisTuberculosisTuberculosis, Multidrug-ResistantAngolaAntitubercular AgentsHumansMaleRisk FactorsAntitubercular Agents

Identifiers

PMID35008058
PMCPMC8922512
OpenAlexW4205885333

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.